S&P 500   2,629.37 (+5.65%)
DOW   22,258.30 (+5.73%)
QQQ   193.91 (+5.75%)
AAPL   255.22 (+5.72%)
FB   163.12 (+5.80%)
MSFT   161.72 (+5.13%)
GOOGL   1,169.97 (+7.07%)
AMZN   1,978.00 (+3.75%)
CGC   14.44 (+8.98%)
NVDA   263.56 (+8.06%)
BABA   196.45 (+4.99%)
MU   45.49 (+10.36%)
GE   7.14 (+6.09%)
TSLA   508.70 (+5.98%)
AMD   46.26 (+8.62%)
T   29.03 (+5.68%)
ACB   0.82 (+2.49%)
F   4.55 (+7.31%)
NFLX   374.08 (+3.41%)
BAC   21.17 (+5.69%)
DIS   98.36 (+4.77%)
S&P 500   2,629.37 (+5.65%)
DOW   22,258.30 (+5.73%)
QQQ   193.91 (+5.75%)
AAPL   255.22 (+5.72%)
FB   163.12 (+5.80%)
MSFT   161.72 (+5.13%)
GOOGL   1,169.97 (+7.07%)
AMZN   1,978.00 (+3.75%)
CGC   14.44 (+8.98%)
NVDA   263.56 (+8.06%)
BABA   196.45 (+4.99%)
MU   45.49 (+10.36%)
GE   7.14 (+6.09%)
TSLA   508.70 (+5.98%)
AMD   46.26 (+8.62%)
T   29.03 (+5.68%)
ACB   0.82 (+2.49%)
F   4.55 (+7.31%)
NFLX   374.08 (+3.41%)
BAC   21.17 (+5.69%)
DIS   98.36 (+4.77%)
S&P 500   2,629.37 (+5.65%)
DOW   22,258.30 (+5.73%)
QQQ   193.91 (+5.75%)
AAPL   255.22 (+5.72%)
FB   163.12 (+5.80%)
MSFT   161.72 (+5.13%)
GOOGL   1,169.97 (+7.07%)
AMZN   1,978.00 (+3.75%)
CGC   14.44 (+8.98%)
NVDA   263.56 (+8.06%)
BABA   196.45 (+4.99%)
MU   45.49 (+10.36%)
GE   7.14 (+6.09%)
TSLA   508.70 (+5.98%)
AMD   46.26 (+8.62%)
T   29.03 (+5.68%)
ACB   0.82 (+2.49%)
F   4.55 (+7.31%)
NFLX   374.08 (+3.41%)
BAC   21.17 (+5.69%)
DIS   98.36 (+4.77%)
S&P 500   2,629.37 (+5.65%)
DOW   22,258.30 (+5.73%)
QQQ   193.91 (+5.75%)
AAPL   255.22 (+5.72%)
FB   163.12 (+5.80%)
MSFT   161.72 (+5.13%)
GOOGL   1,169.97 (+7.07%)
AMZN   1,978.00 (+3.75%)
CGC   14.44 (+8.98%)
NVDA   263.56 (+8.06%)
BABA   196.45 (+4.99%)
MU   45.49 (+10.36%)
GE   7.14 (+6.09%)
TSLA   508.70 (+5.98%)
AMD   46.26 (+8.62%)
T   29.03 (+5.68%)
ACB   0.82 (+2.49%)
F   4.55 (+7.31%)
NFLX   374.08 (+3.41%)
BAC   21.17 (+5.69%)
DIS   98.36 (+4.77%)
Log in

LON:REDXRedx Pharma Share Price, Forecast & News

GBX 15
-0.15 (-0.99 %)
(As of 04/6/2020 02:09 PM ET)
Add
Compare
Today's Range
14.85
Now: GBX 15
15.40
50-Day Range
4.50
MA: GBX 10.25
15
52-Week Range
4.50
Now: GBX 15
15.95
Volume113,862 shs
Average Volume67,755 shs
Market Capitalization£28.50 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Redx Pharma Plc operates as a drug discovery and development company in the United Kingdom. It discovers and develops small molecule drugs for treating cancer and fibrosis. The company is developing RXC004, a porcupine inhibitor for the treatment of pancreatic, biliary, and gastric cancers, as well as melanoma; ROCK inhibitor for treating inflammatory disease related fibrosis; ROCK2, a Rho-associated protein kinase 2 inhibitor for the treatment of diabetic nephropathy, and IPF and NASH/liver fibrosis; and Porcupine (RXC006), a drug for idiopathic pulmonary fibrosis (IPF), non-alcoholic steatohepatitis (NASH), and liver fibrosis. It is also developing Pan-RAF inhibitor for colorectal cancer; and SHP2, a protein-tyrosine phosphatase for receptor tyrosine kinase signaling in cancer cells. Redx Pharma Plc was founded in 2010 and is based in Macclesfield, the United Kingdom.
Read More
Redx Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-151-7064747

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£3.13 million
Cash FlowGBX 3.05 per share
Book ValueGBX 1.20 per share

Profitability

Miscellaneous

Employees51
Market Cap£28.50 million
Next Earnings DateN/A
OptionableNot Optionable

Receive REDX News and Ratings via Email

Sign-up to receive the latest news and ratings for REDX and its competitors with MarketBeat's FREE daily newsletter.


Redx Pharma (LON:REDX) Frequently Asked Questions

How has Redx Pharma's stock been impacted by COVID-19 (Coronavirus)?

Redx Pharma's stock was trading at GBX 6.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, REDX shares have increased by 130.8% and is now trading at GBX 15. View which stocks have been mosted impacted by Coronavirus.

How were Redx Pharma's earnings last quarter?

Redx Pharma PLC (LON:REDX) posted its quarterly earnings results on Monday, November, 19th. The company reported ($7.00) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($6.50) by $0.50. View Redx Pharma's earnings history.

Has Redx Pharma been receiving favorable news coverage?

Press coverage about REDX stock has been trending very negative on Monday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Redx Pharma earned a news impact score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutRedx Pharma.

Who are some of Redx Pharma's key competitors?

What other stocks do shareholders of Redx Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Redx Pharma investors own include Digital Globe Services (DGS), OptiBiotix Health (OPTI), TLA Worldwide (TLA), Be Heard Group (BHRD), salesforce.com (CRM), Encana (ECA), GB Group (GBG), Evgen Pharma (EVG), Burberry Group (BRBY) and Boohoo Group (BOO).

Who are Redx Pharma's key executives?

Redx Pharma's management team includes the following people:
  • Ms. Lisa Mary Whewell Anson, CEO & Director (Age 50)
  • Dr. James Mead, CFO & Exec. Director (Age 41)
  • Dr. Richard Armer, Chief Scientific Officer
  • Dr. Andrew Saunders, Chief Medical Officer (Age 54)
  • Andrew Booth, Sec.

What is Redx Pharma's stock symbol?

Redx Pharma trades on the London Stock Exchange (LON) under the ticker symbol "REDX."

How do I buy shares of Redx Pharma?

Shares of REDX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Redx Pharma's stock price today?

One share of REDX stock can currently be purchased for approximately GBX 15.

How big of a company is Redx Pharma?

Redx Pharma has a market capitalization of £28.50 million and generates £3.13 million in revenue each year. Redx Pharma employs 51 workers across the globe. View additional information about Redx Pharma.

What is Redx Pharma's official website?

The official website for Redx Pharma is http://redxpharma.com/.

How can I contact Redx Pharma?

Redx Pharma's mailing address is Block 33, Mereside,, Alderley Park, MACCLESFIELD, SK10 4TG, United Kingdom. The company can be reached via phone at +44-151-7064747.

This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel